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Hypertension is a risk factor for adverse cardiovascular events.1,2 It is well known that an individual’s risk of 
developing hypertension is affected by genetics, lifestyle 
choices, and the interaction between the two.3,4 However, 
it is now accepted that hypertension in adulthood can also 
be induced by exposure to adverse environmental condi-
tions before birth, which alter fetal development in a way 
that predisposes the individual in later life to a higher risk of 
cardiovascular dysfunction, what is known as developmental 
programming.5,6 Examples of adverse environmental condi-
tions in utero, which can program hypertension, include nu-
tritional deficits,7,8 glucocorticoid treatment,9 and exposure 
to toxins such as tobacco.10 However, in this study, we focus 
on chronic fetal hypoxia, as it is one of the most common 
outcomes of complicated pregnancy in humans.11–15
Studies using mammalian animal models, mostly in 
rodents and sheep, have shown that hypoxic pregnancy can 
program hypertension in the adult offspring via alterations in 
NO biology and sympathetic reactivity in the cardiovascular 
system.16–18 Such studies, together with ours, have used sev-
eral techniques to induce chronic fetal hypoxia, including 
hypoxic chambers,17,19–21 uterine artery blood flow restric-
tion,16,22 placental embolization,23,24 umbilical artery ligation,25 
carunclectomy,26 and exposure to high altitude.27–29 Methods 
such as uterine artery restriction, placental embolization, or 
umbilical artery ligation will also reduce nutrient transfer to 
the fetus, and pregnant mammals placed in hypoxic chambers 
sometimes show reduced food intake,30–32 although this is not 
always the case.20,33 Some studies have attempted to control 
for hypoxia-induced reductions in maternal food intake by 
using a separate group of pair-fed animals.31,32,34 However, this 
only gives an indication of the combined effects of undernu-
trition and hypoxia, compared with undernutrition alone. The 
isolated programming effects of developmental hypoxia are 
harder to elucidate. Another limitation of mammalian mod-
els is that developmental programming of the offspring can 
occur secondary to effects of the adverse environment on 
the placenta and the mother. This complicates the isolation 
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of underlying mechanisms and thereby identification of plau-
sible therapeutic targets for intervention.
In oviparous species, such as in chickens, embryonic de-
velopment can occur in the absence of either a mother or a pla-
centa, and all available nutrition is fixed within the egg from the 
start of incubation. There is no need to consider within-litter 
variation or effects on lactation. Added value is that the tem-
poral milestones of cardiovascular development in humans are 
more similar to the chicken than to rodents, the latter being 
born highly immature and cardiovascular development contin-
uing for weeks past birth.35 Avian species are, therefore, ideally 
placed to isolate the direct programming effects of develop-
mental hypoxia on the offspring’s cardiovascular system and 
underlying genes and signaling pathways. Therefore, using an 
integrative approach by combining invasive and noninvasive 
experiments in vivo with those in isolated organs and at the 
cellular level, in this study, we have tested the hypothesis that 
developmental hypoxia alone can directly program hyperten-
sion in the adult offspring. Further, mechanisms underlying this 
effect include impaired NO biology and enhanced sympathetic 
cardiac reactivity.
Methods
Data, Materials, and Code Disclosure Statement
The data that support the findings of this study are available from the 
corresponding author upon reasonable request.
Ethical Approval
This research was approved under the Animals (Scientific Procedures) 
Act 1986 Amendment Regulations 2012 following ethical review by 
the University of Cambridge Animal Welfare and Ethical Review 
Board.
Animals
Fertilized Bovans Brown chicken eggs (Gallus gallus domesticus) 
were purchased from Medeggs (Henry Stewart & Co, Norfolk, 
United Kingdom). This supplier delivers fertilized eggs in batches 
from a single day’s laying, meaning any one egg used in the pre-
sent programme of work came from a different hen. Fertilized eggs 
were weighed and incubated under normoxic (21% O
2
) or hypoxic 
(13.5%–14% O
2
) conditions (37.9°C, 45% humidity, 12:12-hour 
light:dark cycle, automatic rotation every hour; incubator Models 
75-A and M-240, with humidifier THP 1100-03239 and Humidity 
kit HS Auto-3.5 L; all Masalles, Barcelona, Spain). The levels of 
oxygen, temperature, and humidity inside the incubators were all 
continuously monitored (DD103 DrDAQ Oxygen Sensor; Pico 
Technology, St Neots, United Kingdom). Eggs were candled on 
days 13 and 19 (hatching occurs at ≈day 21) to assess viability. 
On day 19, one cohort of embryos was used to determine measure-
ments in blood. Values for hematocrit were obtained using a micro-
hematocrit centrifuge, in duplicate (Hawksley, United Kingdom). 
Blood glucose and lactate concentrations were measured using a 
glucose/lactate analyzer (Yellow Springs 2300 Stat Plus Glucose/
Lactate Analyzer; YSI, Ltd, Farnborough, United Kingdom). The 
remaining embryos were allowed to hatch in a normoxic (21% O
2
) 
incubator (37.9°C, 60% humidity, 12:12-hour light:dark cycle). 
The hatchlings were weighed, crown rump length (the distance 
from the external occipital protuberance to the base of the tail) was 
measured using a measuring tape and biparietal diameter (BPD; the 
distance between the outside corner of each eye), and the lengths 
of each leg bone were measured using digital calipers. The chicks 
were placed in a brooder (35°C) for 2 to 3 weeks before being 
moved into a barn (room temperature). Chickens that had been 
exposed to normoxic or hypoxic incubation lived in mixed groups 
and had ad libitum access to food and water. Regular measure-
ments of body weight and crown rump length were recorded as 
they grew to adulthood, which we defined as 6 to 7 months of age, 
shortly after the age at which hens start laying eggs.36 Body mass 
index was calculated from these measurements. To control for sex 
differences, only female chickens were kept until adulthood and 




Conscious adult chickens were gently held by an investigator and 
restrained in the supine position. A second investigator then used 
a Toshiba PowerVision 7000 ultrasound machine with a phased 
array 2.0 MHz probe (PSK-20CT) to determine the function 
of the left ventricle (LV), right ventricle, and valves. Ejection 
fraction and fractional shortening were calculated using the 
Teichholz method.37
Chronic Instrumentation
A subset of chickens was anesthetized (2%–2.5% Isoflurane in 4 L O
2
/
min [IsoFlo; Abbott Laboratories, Ltd, Berkshire, United Kingdom]) 
and surgically instrumented with 1 femoral arterial catheter, 2 femoral 
venous catheters, and a femoral arterial Transonic flow probe on the 
contralateral leg, as described in detail elsewhere.38 Following 5 days 
of recovery from surgery, basal blood gases, pH and blood glucose, 
and lactate values were taken (ABL5 and ABL80 from Radiometer, 
Copenhagen, Denmark, and a glucose/lactate analyzer from Yellow 
Springs 2300 Stat Plus, YSI, Ltd, Farnborough, United Kingdom). 
Femoral oxygen and glucose delivery (content×flow) were calcu-
lated.39 To determine in vivo cardiovascular function, chickens were 
placed into a sling within a dark wooden box with air vents. With their 
feet off the floor, the chickens tended to fall asleep, permitting re-
cording of in vivo basal and stimulated cardiovascular function. Data 
were recorded via connection of the arterial catheter to a saline-filled 
pressure transducer (Argon Medical Devices, Plano, TX), which was 
in turn connected to an M-PAQ system (Maastricht-Programmable 
AcQuisition System [1000 Hz sample rate] with IDEEQ software; 
Maastricht Instrument, Maastricht, the Netherlands). The flow probe 
was connected to a Transonic meter (T206; Transonic Systems, 
Ithaca, NY). Four experiments were performed on different days, 
all reagents were obtained from Sigma-Aldrich (Gillingham, United 
Kingdom) unless stated otherwise, and all drugs made up in sterile 
saline. Experiments consisted of (1) intravenous administration of the 
α
1
-adrenergic receptor agonist phenylephrine (PE) in bolus doses (16, 
32, 64, 96, and 128 µg·kg−1) in a randomized order; (2) intravenous ad-
ministration of the vascular smooth muscle–dependent dilator sodium 
nitroprusside (SNP) in bolus doses (1, 5, 10, 15, and 20 µg·kg−1) in 
a randomized order; (3) a single intravenous dose of the eNOS (en-
dothelial NO synthase) inhibitor NG-nitro-L-arginine methyl ester 
(L-NAME; 100 mg·kg−1; Cayman Chemicals, Cambridge, United 
Kingdom); and (4) exposure to an NO clamp, followed by PE treat-
ment. While administration of a single dose of L-NAME permits the 
contribution of basal NO bioavailability to be determined, the NO 
clamp is a technique validated in vivo,40–42 which permits the con-
tribution of stimulated de novo synthesis of NO bioavailability to be 
determined without perturbation to basal cardiovascular function. To 
achieve the NO clamp, an intravenous SNP infusion was started (2 
µg·kg−1·min−1; infusion volume, 0.15 mL·min−1), and a bolus dose of 
L-NAME (100 mg·kg−1) was given via the second venous catheter just 
before the SNP reached the chicken circulation. The rate of SNP in-
fusion was titrated to maintain mean arterial blood pressure (MAP) 
and heart rate at basal values. Once clamped and under conditions 
of NO blockade while maintaining basal cardiovascular function, a 
single dose of PE (64 µg·kg−1) was then administered via the second 
intravenous catheter. At the end of the experiment, the SNP infusion 
was stopped, and recording continued for ≈10 minutes to ensure that 
arterial blood pressure increased, thereby validating the effectiveness 
of the clamp in blocking NO synthesis and the persistence of bioactive 
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Baroreflex Function
Cardiovascular data were transferred into Labchart (Labchart Pro, 
version 7.3.1; AD Instruments, Chalgrove, United Kingdom) for 
analysis. Basal cardiovascular function was determined, and the car-
diovascular responses to drugs calculated by comparing the maximal 
blood pressure and heart rate change from stable baseline just be-
fore administration of each agonist. To generate baroreflex curves, 
the heart rate and blood pressure responses to the SNP and PE doses 
were plotted against each other and a 4-parameter logistic function 
applied.43 Baroreflex gain was then calculated for the average baro-







Chickens were killed by intravenous administration of 2 mL sodium 
barbiturate. There was no significant difference between the 2 groups 
for the age at which the chickens were killed (N, 178±5 days; H, 
186±5 days; P>0.05). Crown rump length, BPD, and leg lengths were 
measured as described above, and organs were dissected and weighed. 
One cohort was reserved for cardiac stereology and a second cohort 
for determining cardiac function in a Langendorff preparation.
Cardiac Stereology
One cohort of chickens underwent perfusion fixation. The heart was 
exposed, a cut made in the right atrium and heparinized saline (100 
IU heparin per mL saline, heparin sodium; Wockhardt, Wrexham, 
United Kingdom) passed into the LV through a needle from a height 
of 170 cm. The chicken was then perfused with a solution of parafor-
maldehyde (Formal Fixx 10% Neutral Buffered Formalin; Thermo 
Fisher Scientific, Loughborough, United Kingdom) at a physiolog-
ical pressure of 16.8 kPa, after which the heart was harvested and 
stored in 10% paraformaldehyde for 3 days before transfer to PBS. 
Perfusion fixed hearts were cut into slices 3-mm thick. Photographs 
were taken and analysis performed using ImageJ (version 1.46; 
National Institutes of Health, Bethesda, MD). Values for the left and 
right ventricular wall and lumen areas of a midcardiac cross section 
were determined by superimposing a point grid onto the sections, 
and wall width was measured. Left and right ventricular wall and 
lumen volumes of the whole heart were estimated using Cavalieri 
Principle.44
Langendorff Preparation
A second cohort of chickens was administered 5000 IU intrave-
nous heparin (5000 IU) in saline immediately before death. Hearts 
were dissected, mounted on a Langendorff apparatus, and perfused 
with Krebs solution (in mmol·L−1: NaCl 118.5, NaHCO
3











 1.9, D-glucose 13.9), 
which was filtered (glass Fiber Prefilter and 8 μm membrane filter; 
both from Millipore, Watford, United Kingdom), heated to 38°C, 




. Pressure generated by the heart 
was measured via insertion of a saline-filled, nonelastic balloon 
into the LV via a small incision in the left atrium. The balloon was 
connected via a rigid saline-filled catheter to a pressure transducer 
(Argon Medical Devices, Plano, TX), which was in turn connected 
to an M-PAQ system (Maastricht-Programmable AcQuisition System 
[1000 Hz sample rate] with IDEEQ software; Maastricht Instrument). 
Following stable baseline, doses of the 
1
-adrenergic receptor agonist 
isoprenaline (1×10−9 to 1×10−7 mol·L−1) and the muscarinic receptor 
agonist carbamylcholine chloride (1×10−8 to 1×10−6 mol·L−1) were 
administered. The data were exported to Labchart for analysis of 
basal cardiac function using basic Labchart functions and the blood 
pressure analysis module. The maximal heart rate responses to the 
agonist doses were then calculated as a percentage of the baseline 
immediately before each dose.
Wire Myography
From the same animals used for the Langendorff preparation, 
second-order femoral arteries were dissected and mounted in 
Krebs solution (in mmol·L−1: NaCl 118.5, NaHCO
3











 2.5, D-glucose 2.8, 37°C, 
95% O
2
) on a 4-chamber wire myograph (610M; Danish Myo 
Technology, Aarhus, Denmark). Vessels were normalized to 90% 
of 16.8 kPa. The responses to 6 doses of potassium (in mmol·L−1: 
16.74, 28.77, 40.80, 64.86, 125, and 250), PE (1×10−9 to 1×10−4 M 
half log increments), SNP (1×10−10 to 1×10−4 mol·L−1, whole log 
increments), and acetylcholine (1×10−9 to 1×10−4 mol·L−1, half log 
increments) were investigated, leaving at least 20 minutes between 
curves. The SNP and acetylcholine curves were performed follow-
ing preconstriction with a suboptimal dose of K+ (response <85% 
of the maximal K+ response). The acetylcholine curve was repeated 
in the presence of L-NAME (1×10−5 mol·L−1; Cayman Chemical, 
Cambridge, United Kingdom) to determine the contribution of 
NO-dependent and NO-independent mechanisms to acetylcholine-
mediated vasorelaxation.45
Data and Statistical Analysis
All experiments were performed for normoxic and hypoxic groups 
in parallel, and investigators for any one outcome were blinded to 
treatments, which were coded. Femoral vascular resistance and 
femoral vascular conductance were calculated following the Ohm 
principle. Vascular resistance was calculated by dividing arterial 
pressure by flow. Vascular conductance was calculated by dividing 
flow by arterial pressure. All values are presented as mean±SEM. 
Data were tested for normality using the Kolmogorov-Smirnov test, 
and transformations applied if necessary. Comparisons between 2 
groups were made with the 2-tailed Student t test for unpaired data 
(SigmaStat, version 3.5; Systat Software, San Jose, CA). In one 
case where the data could not be normalized, the Mann-Whitney U 
test was used. The Student t test with Welch correction was applied 
to data, which were normally distributed but had unequal variances. 
Survival data were analyzed with the χ2 test (SPSS, version 23; 
IBM Analytics, New York, NY). For experiments with a repeated 
measures factor (time or dose), a 2-way mixed-model ANOVA test 
was performed in SPSS. For any mixed-model ANOVA tests, the 
false discovery rate was controlled for,46 and sphericity was tested 
using Maunchly test. Where the assumption of sphericity was vio-
lated, the appropriate correction was made to the df. Basal arterial 
blood pressure at adulthood was related to biometry at hatching. 
Correlations were tested using the 2-tailed Pearson correlation co-
efficient (GraphPad Prism, version 5.0; Graphpad Software, Inc, 
San Diego, CA). For all statistical comparisons, significance was 
accepted when P was <0.05.
Results
Survival, Blood Chemistry, and Growth
Compared with normoxic controls, hypoxic embryos showed 
significantly reduced survival rates, particularly between 
days 1 to 13 of incubation and from day 19 until hatch-
ing (percentage survival days 1–13: 95% (N) versus 54%* 
(H); days 13–19: 97% (N) versus 87%* (H); days 19–21: 
86% (N) versus 23%* (H); *P<0.05; χ2 test). Compared 
with normoxic controls, hypoxic embryos showed ele-
vated hematocrit and blood lactate levels but reduced blood 
glucose concentrations (Figure 1A; Table S1 in the Data 
Supplement). At hatching, hypoxic chicks were growth re-
stricted, with significant reduction in body weight, crown 
rump length, BPD, and hindlimb lengths (Figure 1B; Table 
S1). This could not be explained by differences in egg size 
as there was no significant difference in egg weights at the 
start of incubation (N, 60.4 g ±1.4; H, 59.2 g ±1.4). A signifi-
cant increase in BPD/body weight ratio (Figure 1C) suggests 
that the hypoxic hatchlings were asymmetrically growth re-
stricted, with the reduction in head growth spared relative 
to the rest of the body. As the chickens grew to adulthood, 
chickens that had been incubated under hypoxia remained 
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body mass index when compared with controls (Figure 1D 
and 1E; Table S1). However, by adulthood, the BPD/body 
weight ratio and brain-to-body-weight ratio had normalized, 
and tibial length was significantly increased in birds that had 
been hypoxic during incubation (Table S1).
Arterial Blood Pressure and Vascular Function at 
Adulthood
By adulthood, chickens that had been incubated under hypoxic 
conditions were hypertensive, with significant elevations in 
mean, systolic, and diastolic arterial pressure (Figure 2A and 
2B; Table S2). The rate-pressure product was also significantly 
elevated, but there were no significant differences in basal 
heart rate or in femoral arterial blood flow, vascular resistance, 
or conductance (Table S2). Basal arterial blood gas measure-
ments, hematocrit, and calculations of oxygen and glucose 
hindlimb delivery (content×blood flow) were also similar be-
tween the 2 groups (Table S1). There was a significant negative 
correlation between body weight at hatching and arterial blood 
pressure at adulthood (Figure 2C) and a significant positive cor-
relation between head diameter relative to body weight ratio at 
hatching and arterial blood pressure at adulthood (Figure 2D). 
Administration of a bolus dose of the eNOS inhibitor L-NAME 
caused a rise in arterial blood pressure in all chickens. However, 
the size of the increment was significantly reduced in chickens 
that had been incubated in hypoxia (Figure 3A). Preventing 
basal de novo synthesis of NO with the NO clamp also 
increased the size of the MAP response to a dose of PE in all 
chickens, due to removal of opposing effects of NO. However, 
the size of the increment of this response was again signifi-
cantly smaller in chickens that were incubated under hypoxic 
conditions (Figure 3B). Off the NO clamp, chickens that had 
been incubated in hypoxia showed a significantly reduced MAP 
response to PE doses (Figure 3C). Experiments ex vivo assess-
ing vasomotor reactivity in isolated femoral arterial segments 
using in vitro wire myography showed no significant difference 
in the constrictor responsiveness to K+ or PE or in the dilator re-
sponse to SNP or acetylcholine between the groups (Figure 3D; 
Table S2). There was also no significant difference in the contri-
butions of NO-dependent and NO-independent mechanisms to 
acetylcholine-mediated femoral arterial vasorelaxation.
Cardiac Structure and Function at Adulthood
At adulthood, echocardiography showed that hearts of adult 
chickens incubated under hypoxic conditions had signifi-
cantly increased ejection fraction and fractional shortening 
(Figure 4A and 4B), as well as reduced LV lumenal diameter 
in systole (Table S2). Echocardiographic measurements of 
the right ventricle showed no significant differences (Table 
S2). A plot of cardiac baroreflex function measured in vivo 
revealed a significant increase in baroreflex gain in adult 
chickens incubated under hypoxic conditions (Figure 4C). In 
vitro, hearts of chickens that had been incubated in hypoxia 
showed blunted responsiveness to isoprenaline but enhanced 
responsiveness to carbachol (Figure 4D). The isolated heart 
also demonstrated increased ventricular contractility, with a 
significant increase in the contractility index and in dP/dt 
max (Figure 4E; Table S2).
At adulthood, heart weight relative to body weight and 
LV weight/body weight ratio were both significantly greater 
in chickens that were incubated in hypoxic conditions (Table 
S1). The LV wall cross-sectional area and volume were signifi-
cantly enhanced by hypoxic incubation, either when expressed 
in absolute terms or as a percentage of total cross-sectional 
area or total ventricular volume (Figure 5A through 5F). LV 
lumen areas and volumes were not significantly different 
Figure 1. Hematocrit and biometry. Values are mean±SEM for the chicken embryo hematocrit at day 19 incubation (A), the body weight at hatching (B), 
the biparietal diameter (BPD)/body weight ratio at hatching (C), the body weight post-hatching growth curve (D), the body mass index (BMI) post-hatching 
growth (E) and a photo of representative chicks at hatching (F; N, left; H, right). Measurements are in birds that underwent incubation in normoxic (N, white 
bars or circles) or hypoxic (H, black bars or circles) conditions. (A, n=12; B–E, n=25–32). *Significant effect of hypoxia (P<0.05). Student t test for unpaired 
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between groups (Table S2). Right ventricular lumen area, only 
when expressed as a percentage of total cross-sectional area, 
was reduced in adults of hypoxic incubation, but there were 
no other differences in right ventricular histology (Table S2).
Discussion
The data show that hypoxic incubation increased hemato-
crit and induced asymmetrical growth restriction in the de-
veloping chick. Hypoxia induces the activation of the HIF-1 
(hypoxia-inducible factor-1), which binds to the hypoxia 
response elements of the erythropoietin gene, enhancing its 
transcription.47 Therefore, the data confirm that exposure of 
the chicken embryo to 13.5% to 14% oxygenation from the 
beginning of incubation induced chronic hypoxia. By adult-
hood, chickens from hypoxic incubations remained smaller 
and were significantly hypertensive with LV wall thickening, 
showing in vivo and ex vivo measures of increased cardiac 
sympathetic reactivity, represented by an increase in cardiac 
baroreflex gain, ejection fraction, fractional shortening, dP/
dt
max
, and a decrease in left lumenal end systolic diameter. 
Additional mechanisms included evidence of reduced in 
vivo systemic NO bioavailability, represented by impaired 
in vivo pressor responses to L-NAME and by lower blood 
pressure reactivity to PE during the NO clamp in adult 
chickens that were incubated under hypoxic incubations. 
Therefore, combined, the data support the hypothesis tested 
Figure 2. Arterial blood pressure in adult 
chickens. Values are mean±SEM for systolic 
blood pressure (A) and diastolic blood pressure 
(B) measured in vivo through indwelling arterial 
catheters placed in the descending aorta. C, 
Correlation between hatching body weight 
and mean arterial blood pressure (MAP) at 
adulthood. D, Correlation between hatchling 
biparietal diameter (BPD) relative to body 
weight and MAP at adulthood. Measurements 
are in adult chickens that underwent incubation 
in normoxic (N, white bars or circles) or hypoxic 
(H, black bars or circles) conditions. *Significant 
effect of hypoxia (P<0.05). Student t test for 
unpaired data (A and B, n=7–9) or 2-tailed 
Pearson correlation coefficient (C and D, n=16).
Figure 3. NO bioavailability, pressor 
responses, and vasomotor reactivity in adult 
chickens. Values are mean±SEM for in vivo 
blood pressure change in response to a dose of 
NG-nitro-L-arginine methyl ester (L-NAME; 100 
mg·kg−1; A), the change in the size of the in vivo 
mean arterial blood pressure (MAP) response to 
a dose of phenylephrine (PE; 64 µg·kg−1) on the 
NO clamp compared with off the NO clamp (B), 
an in vivo dose pressor response curve for the 
change in MAP in response to 3 intravenous 
doses of PE (C), and the in vitro femoral 
vascular responsiveness to increasing doses of 
acetylcholine. The inset shows the area above 
the curve (AAC) contributions of NO-dependent 
relaxation (dark gray, downward error bars), 
NO-independent relaxation (light gray, 
downward error bars), and total AAC (dark and 
light gray bars combined, upward error bars; 
D). Measurements were made in adult chickens 
that underwent incubation in normoxic (N, 
white bars or circles) or hypoxic (H, black bars 
or circles) conditions. n=6 to 9 (A and C), n=5 
to 6 (B), and n=7 to 11 (D). *Significant effect 
of hypoxia (P<0.05). Student t test for unpaired 
data for A and B, and 2-way mixed-model 
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that developmental hypoxia alone can directly program hy-
pertension in the adult offspring, independent of effects on 
the mother or placenta. Further, mechanisms underlying this 
phenotype include direct programming effects of develop-
mental hypoxia on NO biology and sympathetic reactivity 
(Figure 6).
When working with animal models of cardiovascular 
dysfunction programmed by adverse conditions before birth, 
the temporal profiles of cardiovascular development between 
species is a highly important translational consideration. 
Rats and mice are altricial species, in which cardiovascular 
maturation continues past birth, becoming completed by 
the second week of postnatal life.35,48 In contrast, chickens, 
nonhuman primates, and humans share similar temporal 
windows of precocial cardiovascular development and mat-
uration.35,49–51 Therefore, in addition to permitting isolation 
of the direct developmental programming effects of chronic 
hypoxia on cardiovascular function at adulthood, cardiovas-
cular data derived from avian models provide useful transla-
tion to the human situation.
According to the National Institute for Health and Care 
Excellence guidelines, human patients are diagnosed as hy-
pertensive when the systolic/diastolic reading exceeds 140/90 
mm Hg.52 There is no equivalent recommendation for chickens, 
and although direct comparisons should be made with caution, 
adult birds that had been incubated under hypoxic conditions 
in the present study had a mean increase in systolic and dias-
tolic blood pressure values of 28.2 and of 18.8 mm Hg above 
control values, respectively. Data from human studies, such 
as the Framingham cohort, report that smaller increments in 
arterial blood pressure than those measured in the present 
study can significantly increase the risk of future cardiovas-
cular dysfunction.53 Further, with each increment of systolic 
and diastolic pressure of 20 and 10 mm Hg, respectively, the 
Figure 4. Cardiac function in adult chickens. Values are mean±SEM for ejection fraction (A), mean±SEM for fractional shortening (B), mean±x and y SEM 
for cardiac baroreflex function curves, with the inset showing the calculated gain of the response (C), mean±SEM for ex vivo chronotropic responses to 
increasing doses of isoprenaline (Iso) and carbachol (Car; D), and mean±SEM for the ex vivo cardiac contractility index (E) in adult chickens that underwent 
incubation in normoxic (N, white bars or circles) or hypoxic (H, black bars or circles) conditions. n=17 to 18 (A and B), n=7 to 9 (C), n=11 to 14 (D), and n=12 
to 13 (E). *Significant effect of hypoxia (P<0.05). Student t test for unpaired data for A–C (inset) and E, and 2-way mixed-model ANOVA for D. For clarity only 
3 points are shown in the cardiac baroreflex function curves. However, all points were taken into account for the fitting of the line and for the calculation of 
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human risk for an adverse cardiovascular event doubles and 
such patients require active preventative lifestyle modifica-
tions.54 Therefore, the magnitude of the hypertension in the 
present study would represent a significant risk of increased 
mortality from cardiovascular disease in humans and is espe-
cially striking given that these chickens are female and only 
young adults—2 factors that would tend to place them in a 
low-risk group for hypertensive diseases.55,56 The hypertension 
observed in this study contrasts with a previous study in which 
adult chickens that were incubated at high altitude were hy-
potensive, rather than hypertensive, at adulthood.57 However, 
in high-altitude hypoxia, the effect of hypobaric hypoxia is 
constant, continuing from in ovo development through to 
adulthood. Therefore, whether high altitude–induced effects 
on cardiovascular function in chickens at adulthood are due to 
hypoxia exposure in ovo or after hatching cannot be isolated. 
Several mammalian studies have also demonstrated that de-
velopment under hypoxic conditions can program hyperten-
sion in the adult offspring.16–18 The present study highlights 
that a least a component of the hypertension programmed de-
velopmentally in mammals is due to the direct effects of hy-
poxia on the developing embryo, independent of any maternal 
or placental effects.
Interestingly, when biometry at hatching was related to ar-
terial blood pressure at adulthood, data in the present study 
showed a significant negative relationship between body 
weight at hatching and MAP at adulthood, and a significant 
positive correlation between the BPD/body weight ratio at 
hatching and MAP at adulthood, with the values derived from 
hypoxic incubations extending toward the extremes of the 
relationships. These discoveries have many commonalities 
with the original findings of Barker et al58 who related reduced 
birth weight with increased rates of cardiovascular disease in 
human populations. Martyn et al59 reported that, in human 
babies, an increase in the ratio of the head circumference to 
birth weight correlates with an increased prevalence of stroke 
in adulthood. These correlations could also support that pro-
grammed hypertension in adulthood in the present model 
results from embryonic growth restriction rather than hypoxia 
in ovo. However, in the field of developmental programming, 
it is widely accepted that fetal growth restriction is a surrogate 
measure resulting from the adverse prenatal conditions that 
induce developmental programming, rather than a prerequisite 
for developmental programming. Support for this statement 
comes from several studies, including ours, that have reported 
programmed cardiovascular dysfunction by prenatal hypoxia 
independent of effects on fetal growth. Therefore, develop-
mental hypoxia can programme cardiovascular dysfunction in 
the adult offspring with or without concomitant fetal growth 
restriction, depending on the time of onset, duration, and 
magnitude of the challenge. As an example, in rats, hypoxic 
pregnancy from days 15 to 21 of gestation (term is ≈21 days), 
reducing the O
2
 to 12%, promotes significant fetal growth re-
striction and programmes cardiovascular dysfunction in the 
adult offspring.30 Conversely, in rat pregnancy, hypoxic preg-
nancy from days 6 to 20 of gestation, reducing O
2
 to 13%, has 
no effect on fetal growth but still programmes cardiovascular 
dysfunction in the adult offspring.20,60
Data in the present study show that blocking basal NO 
production by administration of L-NAME caused a smaller 
increase in arterial blood pressure in chickens, which devel-
oped under hypoxic conditions. Further, under conditions of 
basal NO blockade with the NO clamp,40–42 treatment with 
the α
1
-adrenergic receptor agonist PE also led to a smaller 
increment in arterial blood pressure in chickens from hypoxic 
incubations. Combined, these in vivo data support that one 
mechanism underlying their hypertension is a reduced con-
tribution of circulating NO. The presence of diastolic hyper-
tension also corroborates an increase in peripheral vascular 
resistance and cardiac afterload in chickens from hypoxic 
Figure 5. Cardiac morphology in adult chickens. Values are mean±SEM for left ventricular wall cross-sectional area (A), left ventricular wall cross-
sectional area expressed as a percentage of total ventricular cross-sectional area (B), left ventricular wall volume (C), left ventricular wall volume expressed 
as a percentage of total ventricular volume (D), and representative images from a normoxic (E) and hypoxic (F) chicken. Scales bars represent 1 cm. 
Measurements are from adult chickens that underwent incubation in normoxic (N, white bars) or hypoxic (H, black bars) conditions. n=8 to 9 per group. 
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incubations. In the current study, no significant difference 
was found in the dilator responsiveness of isolated femoral 
resistance vessels to SNP or to acetylcholine stimulation be-
fore and after L-NAME treatment. This may suggest that the 
impairment in NO biology is due to an alteration in NO bioa-
vailability rather than vascular smooth muscle insensitivity to 
NO or to dysfunction in acetylcholine-dependent endothelial 
synthesis. This study could not determine any effects on the 
partial contributions of other endothelium-dependent vasodi-
lators, such as prostacyclin or endothelium-derived hyperpo-
larizing factors because the vessels were preconstricted with 
potassium rather than with noradrenaline or PE. In a com-
prehensive study, Ruijtenbeek et al61 reported that in adult 
chickens, the relaxant responses to acetylcholine in isolated 
femoral arteries determined similarly via in vitro wire myog-
raphy were highly variable and absent in almost 30% of the 
femoral arteries studied. However, in smaller side branches 
of the femoral artery, that study was able to show a reduced 
dilator response to acetylcholine after L-NAME treatment 
in adult chickens incubated in ovo. This supports reduced 
acetylcholine-induced NO release in isolated femoral arterial 
side branches in adult chickens that had been incubated under 
hypoxic conditions.61
Additional data in the present study show significant altera-
tions in the autonomic regulation of cardiac function in birds 
from hypoxic incubations. The arterial blood pressure–heart rate 
relationship shows not only a rightward shift in the set point but 
a much steeper gradient of the relationship, suggesting cardiac 
Figure 6. Summary figure. Hypoxic incubation increased hematocrit and induced asymmetrical growth restriction in the developing chick. By adulthood, 
chickens from hypoxic incubations remained smaller and were significantly hypertensive with left ventricular wall thickening, showing in vivo and ex vivo 
measures of increased cardiac sympathetic reactivity, represented by an increase in cardiac baroreflex gain, ejection fraction, fractional shortening, dP/dtmax, 
and a decrease in left lumenal end systolic diameter. Additional mechanisms included reduced in vivo systemic NO bioavailability, represented by impaired 
in vivo pressor responses to NG-nitro-L-arginine methyl ester and by lower blood pressure reactivity to phenylephrine during the NO clamp in adult chickens, 
which were incubated under hypoxic incubations. Combined, the data support that developmental hypoxia alone can directly program hypertension in the 
adult offspring, independent of effects on the mother or placenta. Further, mechanisms underlying this phenotype include direct programming effects of 
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sympathetic dominance—a finding confirmed by an increase 
in the calculation of the baroreflex gain. The echocardiography 
data showing an increase in ejection fraction and in fractional 
shortening with lower lumenal ventricular diameter at the end 
of systole coupled with the isolated Langendorff data reporting 
an increase in dP/dt
max
 and in the contractility index all further 
support cardiac sympathetic dominance, leading to systolic 
dysfunction. This suggests that hearts from adult birds raised 
from hypoxic incubations are working much harder to maintain 
cardiac output in the face of increased afterload—a response 
that may explain the increase in LV wall size. Increased sym-
pathetic dominance to maintain cardiac function is unsustain-
able, and compensatory cardiac hypertrophy eventually leads to 
dilated cardiomypathy and eventual heart failure in humans.62 
The switch from impaired α
1
-adrenergic receptor to enhanced 
muscarinic receptor responsiveness in hearts isolated from adult 
birds from hypoxic incubations and the impaired in vivo pres-
sor response to α
1
-adrenergic receptor stimulation in the present 
study may, therefore, represent compensatory adaptive responses 
to buffer hypertension and ameliorate cardiovascular compro-
mise. Previous studies in post-hatching chickens have reported 
dilated cardiomyopathy with reduced cardiac β-adrenoreceptor 
sensitivity as a result of hypoxic incubation.63,64 Two elegant 
studies by Ruijtenbeek et al61,65 reported sympathetic hyper-
innervation of femoral arteries of both chick embryos and 
15-week-old chickens that developed under chronic hypoxia. 
Differences between studies are likely the result of different age 
groups or different extents and durations of hypoxic exposure 
promoting varying phenotypic degrees of cardiovascular dys-
function. Analysis of cardiac and vascular adrenoreceptor ex-
pression and catecholamine content in the current model would 
be useful incremental knowledge. However, in the present study, 
this could not be done, as naive frozen tissues, which had not 
been manipulated by the in vivo or in vitro experiments, were 
not generated. Previous studies in mammals have demonstrated 
that exposure to chronic hypoxia during pregnancy can program 
changes in cardiac structure and function at adulthood, reporting 
an increase in sympathetic dominance.20,66–68 In humans, there 
is also evidence of cardiac dysfunction and structural changes 
in offspring of complicated pregnancy.69 Past61,63–65 and present 
studies in birds, therefore, highlight that a least a component of 
the cardiovascular dysfunction programmed developmentally by 
prenatal hypoxia in mammals is due to the direct effects of hy-
poxia on the embryo, independent of any maternal or placental 
effects. Interestingly, in the present study, there was little evi-
dence of any effect of hypoxia in ovo on right ventricular struc-
ture or function at adulthood. Previous studies in mammals68 and 
chickens70 have suggested that development under hypoxic con-
ditions can programme pulmonary hypertension in adulthood. 
It is possible that the level of hypoxic incubation in the present 
study was insufficient to program tissue remodeling associated 
with pulmonary hypertension. However, the data highlight that 
left heart dysfunction can be programmed independent of effects 
on right heart function.
Reduced birth or hatching weight is a well-documented 
consequence of hypoxic development in avian and mam-
malian animal models,19,24,26,32,63,71,72 as well as in human 
pregnancy compromised by high altitude or by placental in-
sufficiency or preeclampsia.73–76 Clinical studies in humans 
have reported that a major factor promoting fetal growth re-
striction in pregnancy complicated by the chronic hypoxia of 
high altitude is altered glucose metabolism in the placenta, 
leading to fetal hypoglycemia.77–79 However, our avian model 
demonstrates both embryonic hypoglycemia and growth re-
striction independent of the existence of a placenta. This sug-
gests that the mechanisms inducing fetal growth restriction in 
human highland pregnancy may not be entirely mediated by 
the placenta or by a reduction in fetal glucose delivery. The 
present data, therefore, underscore the potential for a direct in-
fluence of fetal oxygenation in the regulation of fetal growth.71
Perspectives
In mammals, there are several routes for developmental pro-
gramming of an increased cardiovascular risk in the adult 
offspring in adverse pregnancy. The maternal adaptation to 
pregnancy may be suboptimal. For instance, a maternal car-
diogenic origin of preeclampsia has been proposed, whereby 
women with low prepregnancy cardiac output are at greater 
risk of placental malperfusion and increased placental vas-
cular resistance, thereby promoting fetal growth restriction 
and maternal hypertension.80,81 In turn, offspring of human 
hypertensive pregnancies have increased cardiovascular risk 
factors during childhood.82 Alternatively, the placenta, at 
the interface between the mother and the fetus, may alter its 
metabolism affecting resource distribution, it may alter its 
capacities as a protective barrier, and it may modify the secre-
tion of hormones and agents into the fetal and maternal circu-
lation, which may trigger an increased risk of cardiovascular 
dysfunction in the offspring, as well as in the mother.83–85 For 
example, the release of cytotrophoblast-derived exosomes is 
increased under hypoxic conditions.86 Therefore, in mammals, 
the partial effects of suboptimal pregnancy on the mother, the 
placenta, and the fetus and their contributions to develop-
mental programming are difficult to disentangle. By simpli-
fying the layers of complexity in mammals and employing 
the chicken embryo model, this study provides a significant 
conceptual advance to the field, showing that isolated chal-
lenges to the developing embryo independent of effects on 
the mother and the placenta can by themselves program an 
increased risk of cardiovascular dysfunction in the adult off-
spring. Therefore, this study provides a better understanding 
of the mechanisms involved in the developmental program-
ming of adult-onset hypertension, enabling improved isola-
tion of suitable and rational interventional therapies.
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What Is New?
•	 Fetal development under lower than normal oxygenation, chronic fetal 
hypoxia, programs a greater risk of hypertension in the adult offspring.
•	However, whether this is due to effects of chronic hypoxia on the mother, 
placenta, or fetus is difficult to disentangle.
•	We used the chicken embryo model system to isolate the direct effects 
of hypoxic development in promoting hypertension in the adult offspring.
What Is Relevant?
•	The animals in this study developed significant hypertension in adult life, 
which was not caused by any genetic, postnatal lifestyle factors or ef-
fects on the mother or placenta.
•	Therefore, investigation of mechanisms underlying the programming of 
adult-onset hypertension by direct exposure of the developing embryo to 
adverse conditions before birth is important for the design of new treat-
ments and preventative strategies against hypertension.
Summary
We have isolated a direct effect of chronic fetal hypoxia in program-
ming hypertension in the adult offspring via mechanisms altering 
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